InsidersTradesSigma
Track the 엔지켐생명과학 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엔지켐생명과학 has recorded 9 insider filings. Market capitalisation: €83.8bn. The latest transaction was reported on 7 July 2026 (Other). Among the most active insiders: 남윤희. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
엔지켐생명과학是一家专注于健康和制药领域的公司，在XKRX市场上市。它致力于开发创新的医疗保健解决方案。